Want to join the conversation?
$COF earned $1.99 per share on a continuing operations basis. Net income was up $251MM vs. 3Q14 driven by higher linked quarter pre-provision earnings and slightly lower provision expense. The company had $188MM of non-recurring OpEx in 2Q15. Excluding non-recurring expenses, OpEx were flat vs. the prior year.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)